Richard Hawkins
Directeur Général chez LUMOS PHARMA, INC.
Fortune : 2 M $ au 30/06/2024
Profil
Mr. Richard J.
Hawkins is an Independent Director at Savara, Inc., a Chairman & Chief Executive Officer at Lumos Pharma Sub, Inc., a Chairman & Chief Executive Officer at Lumos Pharma, Inc., a Chairman at Plus Therapeutics, Inc., a President & Chief Executive Officer at id2, Inc, a Chairman at Entvantage Diagnostics, Inc. and an Operating Partner at Havencrest Capital Management LLC.
He is on the Board of Directors at Savara, Inc., Cytori Therapeutics, Inc. and Entvantage Diagnostic Associates LLC.
Mr. Hawkins was previously employed as a Chairman, President & Chief Executive Officer by NewLink Genetics Corp., an Independent Director by SciClone Pharmaceuticals, Inc., a Chairman, President & Chief Executive Officer by LabNow, Inc., a Chairman by Sensus Drug Development Corp., a Chairman, President & Chief Executive Officer by Pharmaco, a Board member by Aravas, Inc., a General Partner by Dominion Ventures, Inc., and a Chairman by LoopOne, Inc. He also served on the board at Aravas, Inc., Covance Biotechnology Services, Inc., Diosynth RTP, Inc. and Synexus Compass, Inc. He received his undergraduate degree from The Ohio University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LUMOS PHARMA, INC.
9,33% | 01/04/2024 | 757 562 ( 9,33% ) | 2 M $ | 30/06/2024 |
SAVARA, INC.
0,01% | 08/04/2024 | 12 741 ( 0,01% ) | 51 346 $ | 30/06/2024 |
PLUS THERAPEUTICS, INC.
0,09% | 08/05/2024 | 4 903 ( 0,09% ) | 7 207 $ | 30/06/2024 |
| 25/07/2018 | 10 ( 1,07% ) | 15 $ | 30/06/2024 |
Postes actifs de Richard Hawkins
| Sociétés | Poste | Début |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Président | 25/01/2018 |
| SAVARA INC. | Directeur/Membre du Conseil | 01/10/2010 |
| LUMOS PHARMA, INC. | Directeur Général | 01/09/2010 |
Havencrest Capital Management LLC
 Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Private Equity Investor | - |
Entvantage Diagnostic Associates LLC
 Entvantage Diagnostic Associates LLC BiotechnologyHealth Technology Entvantage Diagnostic Associates LLC provides medical diagnostics services. The company is headquartered in Austin, TX. | Directeur/Membre du Conseil | - |
Cytori Therapeutics, Inc.
 Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Directeur/Membre du Conseil | - |
Entvantage Diagnostics, Inc.
 Entvantage Diagnostics, Inc. Medical SpecialtiesHealth Technology Entvantage Diagnostics, Inc. develops diagnostic test kits. It includes Collection device and Assay kit products. The company was founded by Joseph Skraba in 2014 and is headquartered in Austin, TX. | Fondateur | - |
id2, Inc
 id2, Inc Information Technology ServicesTechnology Services id2, Inc is a private company that provides custom computer programming services. The company is based in Austin, TX. The company was founded by Richard J. Hawkins and he has been the CEO since incorporation. | Directeur Général | 01/01/1992 |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Directeur Général | 01/09/2010 |
Anciens postes connus de Richard Hawkins
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Richard Hawkins
| The Ohio University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PLUS THERAPEUTICS, INC. | Health Technology |
| SAVARA INC. | Health Technology |
| LUMOS PHARMA, INC. | Health Technology |
| Entreprise privées | 17 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
Sensus Drug Development Corp.
 Sensus Drug Development Corp. Pharmaceuticals: OtherHealth Technology Part of Pfizer Inc., Sensus Drug Development Corp. is a company that develops drugs to treat endocrine disorders. The company is based in San Antonio, TX. The company was founded by John A. Scarlett, Richard J. Hawkins. Sensus Drug Development was acquired by Pharmacia Corp. on March 07, 2001. | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
LabNow, Inc.
 LabNow, Inc. Medical SpecialtiesHealth Technology LabNow, Inc. manufactures medical, dental and hospital equipment and supplies pharmaceutical products. The company was founded on February 20, 2004 and is headquartered in Austin, TX. | Health Technology |
Aravas, Inc.
 Aravas, Inc. Pharmaceuticals: MajorHealth Technology Aravas, Inc. develops innovative drugs for the treatment of serious and life-threatening conditions. It develops dry powder formulations for various therapeutic molecules, including antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules. The firm’s products include AeroVanc, an inhaled dry powder form of vancomycin in a capsule-based inhaler to treat methicillin-resistant staphylococcus aureus infections in patients with cystic fibrosis or other lung-compromising conditions; and AeroCort, a high performance inhaled corticosteroid product for the treatment of asthma in children. The company was founded by Cory Berkland, Chris Marich, Robert N. Neville, Taneli Jouhikainen, Chal Lenge and George Laurence in March 2007 and is headquartered in Austin, TX. | Health Technology |
Synexus Compass, Inc.
 Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Health Services |
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Health Technology |
Diosynth RTP, Inc.
 Diosynth RTP, Inc. BiotechnologyHealth Technology Diosynth RTP, Inc. provides current good manufacturing practices and pharmaceutical products. Its products include monoclonal antibodies, cancer vaccines, fusion proteins, cancer vaccines, and anti coagulants. The company was founded on February 28, 1995 and is headquartered in Morrisville, NC | Health Technology |
Dominion Ventures, Inc.
 Dominion Ventures, Inc. Investment ManagersFinance Dominion Ventures, Inc. (Dominion Ventures) is a ventures capital firm founded in 1985 by Michael K. Lee. The firm is headquartered in Walnut creek, California. | Finance |
id2, Inc
id2, Inc Information Technology ServicesTechnology Services id2, Inc is a private company that provides custom computer programming services. The company is based in Austin, TX. The company was founded by Richard J. Hawkins and he has been the CEO since incorporation. | Technology Services |
| LoopOne, Inc. | |
Pharmaco
 Pharmaco Drugstore ChainsRetail Trade Pharmaco acquires, develops and markets niche pharmaceutical products. The company was founded by Rick J. Hawkins in 1983 and is headquartered in Atlanta, GA. | Retail Trade |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Health Services |
Entvantage Diagnostics, Inc.
Entvantage Diagnostics, Inc. Medical SpecialtiesHealth Technology Entvantage Diagnostics, Inc. develops diagnostic test kits. It includes Collection device and Assay kit products. The company was founded by Joseph Skraba in 2014 and is headquartered in Austin, TX. | Health Technology |
Havencrest Capital Management LLC
Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Finance |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Health Technology |
Entvantage Diagnostic Associates LLC
Entvantage Diagnostic Associates LLC BiotechnologyHealth Technology Entvantage Diagnostic Associates LLC provides medical diagnostics services. The company is headquartered in Austin, TX. | Health Technology |
